NDC 63629-3209-00 - Tizanidine

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
63629-3209
Requested NDC
63629-3209-00
Package NDCs from labels
63629-3209-1, 63629-3209-2, 63629-3209-3, 63629-3209-4, 63629-3209-5, 63629-3209-6, 63629-3209-7, 63629-3209-8, 63629-3209-9, 63629-3209-0, 63629-3209-00
Manufacturer
Bryant Ranch Prepack
Effective date
2021-12-08
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Tizanidine - Bryant Ranch PrepackBryant Ranch Prepack2021-12-08HUMAN PRESCRIPTION DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDCEffectiveRelated label
63629-3209-12022-01-04These highlights do not include all the information needed to use TIZANIDINE TABLETS safely and effectively. See full prescribing information for TIZANIDINE TABLETS. TIZANIDINE tablets, for oral use Initial U.S. Approval: 1996
63629-3209-22022-01-04These highlights do not include all the information needed to use TIZANIDINE TABLETS safely and effectively. See full prescribing information for TIZANIDINE TABLETS. TIZANIDINE tablets, for oral use Initial U.S. Approval: 1996
63629-3209-32022-01-04These highlights do not include all the information needed to use TIZANIDINE TABLETS safely and effectively. See full prescribing information for TIZANIDINE TABLETS. TIZANIDINE tablets, for oral use Initial U.S. Approval: 1996
63629-3209-42022-01-04These highlights do not include all the information needed to use TIZANIDINE TABLETS safely and effectively. See full prescribing information for TIZANIDINE TABLETS. TIZANIDINE tablets, for oral use Initial U.S. Approval: 1996
63629-3209-52022-01-04These highlights do not include all the information needed to use TIZANIDINE TABLETS safely and effectively. See full prescribing information for TIZANIDINE TABLETS. TIZANIDINE tablets, for oral use Initial U.S. Approval: 1996
63629-3209-62022-01-04These highlights do not include all the information needed to use TIZANIDINE TABLETS safely and effectively. See full prescribing information for TIZANIDINE TABLETS. TIZANIDINE tablets, for oral use Initial U.S. Approval: 1996
63629-3209-72022-01-04These highlights do not include all the information needed to use TIZANIDINE TABLETS safely and effectively. See full prescribing information for TIZANIDINE TABLETS. TIZANIDINE tablets, for oral use Initial U.S. Approval: 1996
63629-3209-82022-01-04These highlights do not include all the information needed to use TIZANIDINE TABLETS safely and effectively. See full prescribing information for TIZANIDINE TABLETS. TIZANIDINE tablets, for oral use Initial U.S. Approval: 1996
63629-3209-92022-01-04These highlights do not include all the information needed to use TIZANIDINE TABLETS safely and effectively. See full prescribing information for TIZANIDINE TABLETS. TIZANIDINE tablets, for oral use Initial U.S. Approval: 1996
63629-3209-12020-01-31These highlights do not include all the information needed to use TIZANIDINE TABLETS safely and effectively. See full prescribing information for TIZANIDINE TABLETS. TIZANIDINE tablets, for oral use Initial U.S. Approval: 1996
63629-3209-22020-01-31These highlights do not include all the information needed to use TIZANIDINE TABLETS safely and effectively. See full prescribing information for TIZANIDINE TABLETS. TIZANIDINE tablets, for oral use Initial U.S. Approval: 1996
63629-3209-32020-01-31These highlights do not include all the information needed to use TIZANIDINE TABLETS safely and effectively. See full prescribing information for TIZANIDINE TABLETS. TIZANIDINE tablets, for oral use Initial U.S. Approval: 1996
63629-3209-42020-01-31These highlights do not include all the information needed to use TIZANIDINE TABLETS safely and effectively. See full prescribing information for TIZANIDINE TABLETS. TIZANIDINE tablets, for oral use Initial U.S. Approval: 1996
63629-3209-52020-01-31These highlights do not include all the information needed to use TIZANIDINE TABLETS safely and effectively. See full prescribing information for TIZANIDINE TABLETS. TIZANIDINE tablets, for oral use Initial U.S. Approval: 1996
63629-3209-62020-01-31These highlights do not include all the information needed to use TIZANIDINE TABLETS safely and effectively. See full prescribing information for TIZANIDINE TABLETS. TIZANIDINE tablets, for oral use Initial U.S. Approval: 1996
63629-3209-72020-01-31These highlights do not include all the information needed to use TIZANIDINE TABLETS safely and effectively. See full prescribing information for TIZANIDINE TABLETS. TIZANIDINE tablets, for oral use Initial U.S. Approval: 1996
63629-3209-82020-01-31These highlights do not include all the information needed to use TIZANIDINE TABLETS safely and effectively. See full prescribing information for TIZANIDINE TABLETS. TIZANIDINE tablets, for oral use Initial U.S. Approval: 1996
63629-3209-92020-01-31These highlights do not include all the information needed to use TIZANIDINE TABLETS safely and effectively. See full prescribing information for TIZANIDINE TABLETS. TIZANIDINE tablets, for oral use Initial U.S. Approval: 1996

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
63629-3209-0Tizanidine40 in 1 BOTTLETABLET404
63629-3209-1Tizanidine30 in 1 BOTTLETABLET304
63629-3209-2Tizanidine60 in 1 BOTTLETABLET604
63629-3209-3Tizanidine90 in 1 BOTTLETABLET904
63629-3209-4Tizanidine120 in 1 BOTTLETABLET1204
63629-3209-5Tizanidine100 in 1 BOTTLETABLET1004
63629-3209-6Tizanidine84 in 1 BOTTLETABLET844
63629-3209-7Tizanidine28 in 1 BOTTLETABLET284
63629-3209-8Tizanidine21 in 1 BOTTLETABLET214
63629-3209-9Tizanidine160 in 1 BOTTLETABLET1604

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
63629-3209TIZANIDINE TABLET [BRYANT RANCH PREPACK]4Current NDC, Legacy NDC, 10 package rows20220104_82084f4e-00d0-c298-c13a-88a6c0860b02.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
63629-3209-1EA - Each63629-320994755468-7210-4cee-b98c-89f09f32693112012-07-24
63629-3209-2EA - Each63629-32094aa59f0a-130d-4d1e-8a57-022bef73733512012-07-24
63629-3209-3EA - Each63629-32094c77db4e-b653-4e2e-b251-20b78df0b22a12012-07-24
63629-3209-4EA - Each63629-32098db8bbac-e0cd-474d-bde5-339eef463e9612012-07-24
63629-3209-5EA - Each63629-320965add7e8-b489-4bb2-ab82-23bb1a651c9e12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
Tizanidine HydrochlorideACTIVE INGREDIENTB53E3NMY5CTIZANIDINE TABLET [BRYANT RANCH PREPACK]1
TizanidineACTIVE MOIETY6AI06C00GWTIZANIDINE TABLET [BRYANT RANCH PREPACK]1
anhydrous lactoseINACTIVE INGREDIENT3SY5LH9PMKTIZANIDINE TABLET [BRYANT RANCH PREPACK]1
cellulose, microcrystallineINACTIVE INGREDIENTOP1R32D61UTIZANIDINE TABLET [BRYANT RANCH PREPACK]1
silicon dioxideINACTIVE INGREDIENTETJ7Z6XBU4TIZANIDINE TABLET [BRYANT RANCH PREPACK]1
stearic acidINACTIVE INGREDIENT4ELV7Z65APTIZANIDINE TABLET [BRYANT RANCH PREPACK]1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 35 · 700 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
tizanidine hydrochlorideTIZANIDINE HYDROCHLORIDEAdvagen Pharma Limited7f39499a-98cf-4d13-9b07-ccb5c22e43c82026-11-04Warnings, Adverse reactionsExact identifier
unii: B53E3NMY5C
TizanidineTIZANIDINEAmerican Health Packaging3670f9e3-988d-48e6-9df0-d403d699e08a2026-10-30Warnings, Adverse reactionsExact identifier
application number: ANDA076286
unii: B53E3NMY5C
TizanidineTIZANIDINEPD-Rx Pharmaceuticals, Inc.fd16a25c-67b6-ae6c-e053-6394a90aeee02026-10-28Warnings, Adverse reactionsExact identifier
rxcui: 313412
rxcui: 313413
unii: B53E3NMY5C
TizanidineTIZANIDINEPD-Rx Pharmaceuticals, Inc.fdf4f09d-4537-a438-e053-6394a90a573d2026-10-28Warnings, Adverse reactionsExact identifier
rxcui: 313413
unii: B53E3NMY5C
TizanidineTIZANIDINESt. Mary's Medical Park Pharmacycfd52c0c-a7c2-e23d-e053-2a95a90abbd12026-10-23Warnings, Adverse reactionsExact identifier
application number: ANDA076286
rxcui: 313412
unii: B53E3NMY5C
TizanidineTIZANIDINEREMEDYREPACK INC.17ca23af-c88f-4235-930a-d7568051696f2026-10-15Warnings, Adverse reactionsExact identifier
application number: ANDA076286
rxcui: 313413
unii: B53E3NMY5C
tizanidineTIZANIDINECardinal Health 107, LLCeeb18068-75c8-42d0-a006-1b134648333f2026-10-06Warnings, Adverse reactionsExact identifier
rxcui: 313413
unii: B53E3NMY5C
TIZANIDINE HYDROCHLORIDETIZANIDINE HYDROCHLORIDEPreferred Pharmaceuticals Inc.ae9b6808-632f-4204-8581-bf146dcab69f2026-10-05Warnings, Adverse reactionsExact identifier
unii: B53E3NMY5C
TIZANIDINE HYDROCHLORIDETIZANIDINE HYDROCHLORIDEPreferred Pharmaceuticals Inc.6439a7ef-1b22-4fa1-9be3-eedd3cd241912026-10-05Warnings, Adverse reactionsExact identifier
unii: B53E3NMY5C
TizanidineTIZANIDINEPreferred Pharmaceuticals, Inc.32c3be66-5398-425c-ac65-e57ba819bb432026-10-05Warnings, Adverse reactionsExact identifier
application number: ANDA076286
rxcui: 313413
unii: B53E3NMY5C
tizanidineTIZANIDINEPreferred Pharmaceuticals Inc.f0e4eb26-6733-4df6-bb3c-86bf4d976f422026-10-05Warnings, Adverse reactionsExact identifier
rxcui: 313413
unii: B53E3NMY5C
TizanidineTIZANIDINEPreferred Pharmaceuticals Inc.3c993e3c-ee52-45a7-be39-60eaac7a10922026-10-02Warnings, Adverse reactionsExact identifier
application number: ANDA076286
rxcui: 313412
unii: B53E3NMY5C
TizanidineTIZANIDINEA-S Medication Solutions180985f0-3fbd-4868-a826-b84101618a032026-10-01Warnings, Adverse reactionsExact identifier
application number: ANDA076286
rxcui: 313412
rxcui: 313413
unii: B53E3NMY5C
Tizanidine HydrochlorideTIZANIDINE HYDROCHLORIDEApotex Corp.3dd09a0d-a782-1d6d-a552-b71e5bcbf2fe2026-09-18Warnings, Adverse reactionsExact identifier
unii: B53E3NMY5C
tizanidineTIZANIDINEApotex Corp.01c0d3d3-2373-a1b7-822a-80a66291a2482026-09-18Warnings, Adverse reactionsExact identifier
rxcui: 313412
rxcui: 313413
unii: B53E3NMY5C
Lymph Tonic IIECHINACEA (ANGUSTIFOLIA), COLLINSONIA CANADENSIS, PHYTOLACCA DECANDRA, KALI IODATUM, PINUS SYLVESTRIS, PIX LIQUIDA, FERRUM PHOSPHORICUM, AESCULUS HIPPOCASTANUM, BARYTA CARBONICA, BERBERIS VULGARIS, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CAUSTICUM, HEPAR SULPHURIS CALCAREUM, KREOSOTUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, NITRICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SILICEA, STELLARIA MEDIA, SULPHUR, TEREBINTHINA, THUJA OCCIDENTALIS, BUFO RANABioActive Nutritional, Inc.0e3265b0-b210-4a4c-80d2-8a9712981d4e2026-09-17WarningsExact identifier
unii: ETJ7Z6XBU4
tizanidine hydrochlorideTIZANIDINE HYDROCHLORIDEPD-Rx Pharmaceuticals, Inc.e19f83b8-8c59-415c-a744-7473d46ab0ca2026-09-16Warnings, Adverse reactionsExact identifier
unii: B53E3NMY5C
tizanidine hydrochlorideTIZANIDINE HYDROCHLORIDEPD-Rx Pharmaceuticals, Inc.e94aa8b1-74ed-46b7-94c5-53d5d5630be62026-09-16Warnings, Adverse reactionsExact identifier
unii: B53E3NMY5C
tizanidine hydrochlorideTIZANIDINE HYDROCHLORIDEPD-Rx Pharmaceuticals, Inc.d7d5dce0-f8a2-404d-9e87-e2235f5d32682026-09-16Warnings, Adverse reactionsExact identifier
unii: B53E3NMY5C
Psoriasis ControlCENTELLA ASIATICA, SODIUM CHLORIDE, AND SILICON DIOXIDEForces of Nature2db33771-0bb9-49f8-84fa-dddc28e4ba262026-09-04WarningsExact identifier
unii: ETJ7Z6XBU4

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.